- Lipid point-of-care testing (POCT) devices, which enable rapid, on-site analysis of lipid profiles such as cholesterol and triglycerides, are becoming increasingly essential in primary care, pharmacies, and home settings due to their convenience, speed, and ability to support timely clinical decision-making for cardiovascular health management
- The growing demand for lipid POCT is primarily driven by the rising global burden of cardiovascular and metabolic disorders, increasing emphasis on preventive healthcare, and patient preference for decentralized, real-time diagnostic solutions
- North America dominated the lipid POCT market with the largest revenue share of 42.1% in 2024, attributed to a well-established healthcare infrastructure, widespread awareness of cardiovascular risks, and early adoption of innovative diagnostic technologies across clinics and community health programs
- Asia-Pacific is expected to be the fastest growing region in the lipid POCT market during the forecast period due to expanding healthcare access, government initiatives for early disease detection, and a growing elderly population susceptible to lipid-related disorders
- Consumables and Kits segment dominated the Lipid POCT market with a market share of 61.9% in 2024, driven by its recurring demand for single-use test strips and reagents, which are essential for each diagnostic cycle
